Clinical Trial Update: Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of fludarabine, cyclophosphamide, and rituximab, with or without lumiliximab, in previously untreated chronic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)
• Lumiliximab (Lumiliximab)
• Rituximab (rituximab)

Snippet

Sponsor: Biogen | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: TERMINATED